Literature DB >> 24034068

Pemphigus.

Frank A Santoro1, Eric T Stoopler, Victoria P Werth.   

Abstract

Pemphigus vulgaris and paraneoplastic pemphigus are 2 subtypes of pemphigus that involve the oral mucosa. These autoimmune blistering disorders have antibodies targeted against proteins of keratinocyte adhesion, thereby causing acantholysis. Clinical findings include oral erosions and flaccid cutaneous bullae and erosions. Further malignancy workup in patients with suspected paraneoplastic pemphigus is warranted. Retrospective uncontrolled studies suggest that immunosuppressive agents reduce mortality in pemphigus vulgaris and cohort uncontrolled studies of rituximab, a monoclonal antibody against CD20, suggest it is an effective treatment for refractory patients. Ongoing studies will define its role in early disease. Published by Elsevier Inc.

Entities:  

Keywords:  Acantholysis; Blistering disorder; Oral erosions; Paraneoplastic pemphigus; Pemphigus; Rituximab; Stomatitis

Mesh:

Substances:

Year:  2013        PMID: 24034068      PMCID: PMC3883438          DOI: 10.1016/j.cden.2013.06.002

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  39 in total

Review 1.  Immunofluorescence in dermatology.

Authors:  D F Mutasim; B B Adams
Journal:  J Am Acad Dermatol       Date:  2001-12       Impact factor: 11.527

Review 2.  Nail destruction in pemphigus vulgaris.

Authors:  A Kolivras; P Gheeraert; J André
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

3.  Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris.

Authors:  Tim A Hodgson; Forhana Malik; Anne M Hegarty; Stephen R Porter
Journal:  Eur J Dermatol       Date:  2003 Mar-Apr       Impact factor: 3.328

Review 4.  Paraneoplastic pemphigus.

Authors:  Grant J Anhalt
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

5.  Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.

Authors:  G Avgerinou; D-K Papafragkaki; A Nasiopoulou; V Markantoni; A Arapaki; M Servitzoglou; A Katsambas; P G Stavropoulos
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-01-05       Impact factor: 6.166

6.  Pemphigus vulgaris and internal malignancy.

Authors:  L S Krain; S M Bierman
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

7.  Pemphigus associated with giant lymph node hyperplasia.

Authors:  J Redon; G Sorni; A Gonzalez-Molina; M Caballero; J Baguena
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

8.  Association of oral pemphigus with chronic lymphocytic leukemia.

Authors:  G C Laskaris; S S Papavasiliou; O D Bovopoulou; G D Nicolis
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1980-09

9.  The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.

Authors:  K E Harman; P T Seed; M J Gratian; B S Bhogal; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

10.  Severe erosive stomatitis and giant lymph node hyperplasia of retroperitoneum (Castleman's tumor).

Authors:  H Tagami; K Sagawa; S Imamura; T Uchiyama; K Takatsuki
Journal:  Dermatologica       Date:  1978
View more
  9 in total

1.  Family dermatology life quality index in patients with pemphigus vulgaris: A cross-sectional study.

Authors:  Sarvin Sajedianfard; Farhad Handjani; Nasrin Saki; Alireza Heiran
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

Review 2.  Oral manifestations of systemic disease.

Authors:  S R Porter; V Mercadante; S Fedele
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

3.  The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study.

Authors:  Fahimeh Rezazadeh; Maryam Moshaverinia; Farhad Handjani; Fatemeh Khoshkholgh; Nasrin Saki; Alireza Heiran
Journal:  Malays J Med Sci       Date:  2020-04-30

4.  Oral pemphigus vulgaris: A case report with direct immunofluorescence study.

Authors:  Sangeetha Jeevan Kumar; S P Nehru Anand; Nandhini Gunasekaran; Rajkumar Krishnan
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

Review 5.  Validation studies of outcome measures in pemphigus.

Authors:  Sarah Hanna; Minhee Kim; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2016-12-10

6.  A Case of Acute Pemphigus Vulgaris Relapses Associated with Cocaine Use and Review of the Literature.

Authors:  Omar Jiménez-Zarazúa; Andrés Guzmán-Ramírez; Lourdes N Vélez-Ramírez; Jesús A López-García; Leticia Casimiro-Guzmán; Jaime D Mondragón
Journal:  Dermatol Ther (Heidelb)       Date:  2018-11-10

7.  Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent.

Authors:  Pawel Pietkiewicz; Monika Bowszyc-Dmochowska; Justyna Gornowicz-Porowska; Marian Dmochowski
Journal:  Front Med (Lausanne)       Date:  2018-08-14

8.  Pemphigus vulgaris: a case report.

Authors:  Janumpally Varshitha Thanmai; Gantala Ramlal; Katne Tejaswi; Inukonda Lakshmi Mounica
Journal:  Pan Afr Med J       Date:  2022-07-07

Review 9.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.